Generation and characterization of lymphokine-activated killer cells from non-Hodgkin's lymphoma patients

This publication has 28 references indexed in Scilit:

• A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells
  International Journal of Cancer, 1989
• Differential Activation of Lymphokine-activated Killer Cells with Different Surface Phenotypes by Cultivation with Recombinant Interleukin 2 or T-cell Growth Factor in Gastric Cancer Patients
  Japanese Journal of Cancer Research, 1989
• Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
  Japanese Journal of Cancer Research, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
  Annual Review of Immunology, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphoma
  European Journal of Cancer and Clinical Oncology, 1985
• Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli
  Science, 1984
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982